Abstract
Purpose
Promoting urine glucose excretion (UGE) is an attractive approach for the treatment of diabetes. Obesity is associated with increased risk for type 2 diabetes. This study was aimed to investigate the association of waist-to-hip ratio (WHR), a simple measure of abdominal obesity, with UGE determined in subjects without previous history of diabetes.
Methods
We studied the correlation of WHR with UGE in 7485 participants without previous history of diabetes. All participants were given a standard 75 g glucose solution. Clinical parameters and demographic characteristics were assessed. Multiple linear regression analysis and multivariate logistic regression analysis were performed to determine the association of WHR with UGE.
Results
Individuals with high WHR (H-WHR) exhibited significantly lower UGE compared to those with low WHR (L-WHR), in either normal glucose tolerance group or pre-diabetes group. In newly diagnosed diabetes group, individuals with H-WHR also showed lower UGE than those with L-WHR; however, no statistical significance was observed. After adjustment for potential confounding factors, including age, genders, and blood glucose level, WHR was negatively associated with UGE (β = −250.901, 95% CI: −471.891 to −29.911, p = 0.026). However, no significant association was observed between BMI and UGE. Furthermore, multivariable logistic regression model showed that individuals with H-WHR were more likely to have low UGE (OR = 0.83, 95% CI: 0.71–0.97, p = 0.018).
Conclusions
Individuals with H-WHR were at risk for decreased UGE. This study suggests that WHR, but not BMI, might be an important determinant of UGE.
Similar content being viewed by others
References
J.E. Gerich, Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet. Med. 27, 136–142 (2010)
R.A. DeFronzo, J.A. Davidson, P.S. Del, The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. Diabetes Obes. Metab. 14, 5–14 (2012)
R.A. DeFronzo, M. Hompesch, S. Kasichayanula, X. Liu, Y. Hong, M. Pfister, L.A. Morrow, B.R. Leslie, D.W. Boulton, A. Ching, F.P. LaCreta, S.C. Griffen, Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes. Diabetes Care 36, 3169–3176 (2013)
A. Osaki, S. Okada, T. Saito, E. Yamada, K. Ono, Y. Niijima, H. Hoshi, M. Yamada, Renal threshold for glucose reabsorption predicts diabetes improvement by sodium-glucose cotransporter 2 inhibitor therapy. J. Diabetes Investig. 7, 751–754 (2016)
J.P. Wilding, The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors. Metab. Clin. Exp. 63, 1228–1237 (2014)
E. Ferrannini, Sodium-glucose co-transporters and their inhibition: clinical physiology. Cell Metab. 26, 27–38 (2017)
J. Chen, H. Guo, S. Yuan, C. Qu, T. Mao, S. Qiu, W. Li, X. Wang, M. Cai, H. Sun, B. Wang, X. Li, Z. Sun, Efficacy of urinary glucose for diabetes screening: a reconsideration. Acta Diabetol. (2018). https://doi.org/10.1007/s00592-018-1212-1
J. Lu, R.F. Bu, Z.L. Sun, Q.S. Lu, H. Jin, Y. Wang, S.H. Wang, L. Li, Z.L. Xie, B.Q. Yang, Comparable efficacy of self-monitoring of quantitative urine glucose with self-monitoring of blood glucose on glycaemic control in non-insulin-treated type 2 diabetes. Diabetes Res. Clin. Pract. 93, 179–186 (2011)
C.P. Kovesdy, S.L. Furth, C. Zoccali, Obesity and kidney disease: hidden consequences of the epidemic. Afr. J. Prim. Health Care Fam. Med. 9, e1–1e3 (2017)
A. Misra, L. Khurana, Obesity-related non-communicable diseases: South Asians vs White Caucasians. Int. J. Obes. (Lond.). 35, 167–187 (2011)
A. Chandra, M. Biersmith, R. Tolouian, Obesity and kidney protection. J. Nephropathol. 3, 91–97 (2014)
S.J. Pinto-Sietsma, G. Navis, W.M. Janssen, D. de Zeeuw, R.O. Gans, P.E. de Jong, A central body fat distribution is related to renal function impairment, even in lean subjects. Am. J. Kidney Dis. 41, 733–741 (2003)
JI. Lakkis, MR. Weir, Obesity and kidney disease. Prog. Cardiovasc. Dis. 61, 157–167 (2018).
X.D. Yue, J.Y. Wang, X.R. Zhang, J.H. Yang, C.Y. Shan, M.Y. Zheng, H.Z. Ren, Y. Zhang, S.H. Yang, Z.H. Guo, B. Chang, B.C. Chang, Characteristics and impact factors of renal threshold for glucose excretion in patients with type 2 diabetes mellitus. J. Korean Med. Sci. 32, 621–627 (2017)
S. Yusuf, S. Hawken, S. Ounpuu, L. Bautista, M.G. Franzosi, P. Commerford, C.C. Lang, Z. Rumboldt, C.L. Onen, L. Lisheng, S. Tanomsup, P. Wangai, F. Razak, A.M. Sharma, S.S. Anand, Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366, 1640–1649 (2005)
J.P. Reis, C.A. Macera, M.R. Araneta, S.P. Lindsay, S.J. Marshall, D.L. Wingard, Comparison of overall obesity and body fat distribution in predicting risk of mortality. Obesity (Silver Spring) 17, 1232–1239 (2009)
J. Chen, H.J. Guo, S.H. Qiu, W. Li, X.H. Wang, M. Cai, B. Wang, X.N. Li, Z.L. Sun, Identification of newly diagnosed diabetes and prediabetes using fasting plasma glucose and urinary glucose in a Chinese population: a multicenter cross-sectional study. Chin. Med. J. 131, 1652–1657 (2018)
M.A. van Baak, The peripheral sympathetic nervous system in human obesity. Obes. Rev. 2, 3–14 (2001)
R.H. Elliott, V.B. Matthews, C. Rudnicka, M.P. Schlaich, Is it time to think about the sodium glucose co-transporter 2 sympathetically? Nephrology (Carlton) 21, 286–294 (2016)
W. Ji, M. Zhao, M. Wang, W. Yan, Y. Liu, S. Ren, J. Lu, B. Wang, L. Chen, Effects of canagliflozin on weight loss in high-fat diet-induced obese mice. PLoS One 12, e0179960 (2017)
S. Fujioka, Y. Matsuzawa, K. Tokunaga, S. Tarui, Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metab. Clin. Exp. 36, 54–59 (1987)
S.B. Solerte, M. Fioravanti, S. Severgnini, M. Rondanelli, S. Precerutti, G. Vignati, E. Ferrari, Hyperinsulinemia and glucagon serum concentrations influence renal hemodynamics and urinary protein loss in normotensive patients with central obesity. Int. J. Obes. Relat. Metab. Disord. 24(Suppl 2), S122–S123 (2000)
N. Nakamura, T. Matsui, Y. Ishibashi, S. Yamagishi, Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation. Diabetol. Metab. Syndr. 7, 48 (2015)
J.E. Hall, E.D. Crook, D.W. Jones, M.R. Wofford, P.M. Dubbert, Mechanisms of obesity-associated cardiovascular and renal disease. Am. J. Med. Sci. 324, 127–137 (2002)
K. Nagai, S. Yoshida, H. Konishi, Gender differences in the gene expression profiles of glucose transporter GLUT class I and SGLT in mouse tissues. Pharmazie 69, 856–859 (2014)
Acknowledgements
We owe our sincere thanks to the local research teams and colleagues for assistance in participant recruitment. We are grateful to many residents of Jiangsu Province who participated in this study. We thank all the staff who were involved in this study for their important contributions.
Funding
This study was supported by grants from the Excellence Project of Southeast University, the National Key R&D Program of China (2016YFC1305700) and the National Key Scientific Instrument and Equipment Development Project of China (No. 51627808). The funders had no roles in study design, data collection, data analysis, interpretation or writing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the ethical review committee of Jiangsu Provincial Center for Disease Control and Prevention (JSJK2016-B003-03).
Informed consent
Informed consent was obtained from all participants included in the study.
Rights and permissions
About this article
Cite this article
Chen, J., Qiu, S., Guo, H. et al. Increased waist-to-hip ratio is associated with decreased urine glucose excretion in adults with no history of diabetes. Endocrine 64, 239–245 (2019). https://doi.org/10.1007/s12020-018-1802-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-018-1802-2